Preterm Birth Prevention & Management Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Preterm Birth Prevention and Management Market is Segmented by Therapy Type (Progesterone Therapy, Corticosteroid Therapy, Tocolytics Therapy, Antibiotics Therapy, Heparin Profylaxis Therapy, and Others), Route of Administration (Oral, Parenteral, and Vaginal), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South America). The report offers the value (in USD million) for the above segments.

Preterm Birth Prevention & Management Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Preterm Birth Prevention and Management Industry Overview

The global preterm birth prevention and management market is moderately competitive and consists of a few major players. Companies like AbbVie Inc., ObsEva, Covis Pharma GmbH (AMAG Pharmaceuticals, Inc.), Bayer AG, Ferring B.V., Merck & Co., Inc., Viatris Inc., Pfizer Inc., and Takeda Pharmaceutical Company Limited, among others, hold a substantial market share in the market.

Preterm Birth Prevention and Management Market Leaders

  1. Covis Pharma GmbH. (AMAG Pharmaceuticals, Inc.)

  2. Ferring B.V.

  3. Pfizer Inc.

  4. Takeda Pharmaceutical Company Limited.

  5. ObsEva

  6. *Disclaimer: Major Players sorted in no particular order
Preterm Birth Prevention and Management Market Concentration

Preterm Birth Prevention and Management Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?